hrcak mascot   Srce   HID

ADMET and DMPK, Vol. 4 No. 3, 2016.


Datum izdavanja: rujna 2016.

Objavljen na Hrčku: 1. 10. 2016.
Sadržaj Puni tekst
ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors (str.182-185) engleskipdf 433 KB
Godefridus Peters, Kin Tam
Uvodnik
 
Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer (str.186-211) engleskipdf 586 KB
Jonathan R. Thompson, Smitha P. Menon, Grace K. Dy
Pregledni rad
 
Cardiovascular safety of protein kinase inhibitors: putting their “QT-phobia” in perspective (str.212-231) engleskipdf 590 KB
Rashmi Shah
Pregledni rad
 
Cross talk of c-Jun N-terminal kinase and p38 map kinase modulate insulin and TNFα-stimulated VCAM-1 expression in rat aorta endothelial cells (str.232-240) engleskipdf 774 KB
Gregory B. Pott, Mark Tsurudome, Jamie Bui, Chelsea Gardner, Marc Goalstone
Izvorni znanstveni članak
 
Dose optimization of ceftriaxone-vancomycin combination using fractional inhibitory concentration kinetics in resistant bacteria (str.241-260) engleskipdf 959 KB
Vishnu D Sharma, Aman Singla, Manu Chaudhary, Mukesh Kumar, Anuj Bhatnagar, Shailesh Kumar, Manish Taneja
Izvorni znanstveni članak
 
Evaluation of P-glycoprotein expression in pain relevant tissues: understanding translation of efflux from preclinical species to human (str.261-268) engleskipdf 844 KB
Renu Singh Dhanikula, Cyrla Hoffert, Rebecca Grant, Denis Projean, Rosemarie Panetta, Dajan O’Donnell, Marie Roumi
Izvorni znanstveni članak
 
Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A, OATP, and P-glycoprotein transporters (str.269-279) engleskipdf 595 KB
Thirumaleswara Goud, Srinivas Maddi, Nayakanti Devanna, Thatipamula Rajendra Prasad
Izvorni znanstveni članak
 
Posjeta: 6.690 *